MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Early Increase in Blood Supply in Patients With Barrett's Esophagus

Completed

Conditions: Barrett's Esophagus

First Posted Date: 2010-08-26

Last Posted Date: 2016-04-22

Lead Sponsor: Mayo Clinic

Target Recruit Count: 90

Registration Number: NCT01188980

Locations: 🇺🇸
Mayo Clinic, Jacksonville, Florida, United States

Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis

Phase 1

Completed

Conditions: Cirrhosis
Portal Hypertension
Esophageal Varices

Interventions: Drug: Saline
Drug: Long acting octreotide 10mg
Drug: Long acting Octreotide 30mg

First Posted Date: 2010-08-25

Last Posted Date: 2010-08-25

Lead Sponsor: Mayo Clinic

Target Recruit Count: 39

Registration Number: NCT01188733

Role of Endogenous Estrogen in Growth-Hormone Regulation in Postmenopausal Women

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Fulvestrant

First Posted Date: 2010-08-23

Last Posted Date: 2015-03-27

Lead Sponsor: Mayo Clinic

Target Recruit Count: 30

Registration Number: NCT01186796

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Integrated Behavioral Intervention for Cigarette Smoking and Binge Drinking in Young Adults

Not Applicable

Completed

Conditions: for Cigarette Smoking and Binge Drinking Cessation

Interventions: Behavioral: behavioral intervention

First Posted Date: 2010-08-18

Last Posted Date: 2014-03-26

Lead Sponsor: Mayo Clinic

Target Recruit Count: 170

Registration Number: NCT01184261

Locations: 🇺🇸
Mayo Clinic, Jacksonville, Florida, United States

Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA)

Completed

Conditions: Pulmonary Arterial Hypertension

First Posted Date: 2010-08-13

Last Posted Date: 2012-02-07

Lead Sponsor: Mayo Clinic

Target Recruit Count: 24

Registration Number: NCT01181284

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

MEmbranous Nephropathy Trial Of Rituximab

Phase 2

Completed

Conditions: Idiopathic Membranous Nephropathy

Interventions: Drug: Rituximab
Drug: Cyclosporine

First Posted Date: 2010-08-11

Last Posted Date: 2019-04-30

Lead Sponsor: Mayo Clinic

Target Recruit Count: 130

Registration Number: NCT01180036

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada
🇺🇸
Ohio State University, Columbus, Ohio, United States
🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

and more 18 locations

Short-Term Fasting Before Chemotherapy in Treating Patients With Cancer

Not Applicable

Completed

Conditions: Malignant Neoplasm

Interventions: Other: questionnaire administration
Other: preventative dietary intervention
Other: laboratory biomarker analysis

First Posted Date: 2010-08-05

Last Posted Date: 2018-12-12

Lead Sponsor: Mayo Clinic

Target Recruit Count: 12

Registration Number: NCT01175837

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Teriparatide for Postsurgical Hypoparathyroidism

Phase 2

Terminated

Conditions: Hypoparathyroidism Post-surgical

Interventions: Drug: Teriparatide

First Posted Date: 2010-07-28

Last Posted Date: 2014-12-22

Lead Sponsor: Mayo Clinic

Target Recruit Count: 5

Registration Number: NCT01171690

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Varenicline and Alcohol in Inpatient Addictions Program (IAP)

Phase 3

Terminated

Conditions: Alcoholism
Nicotine Dependence

Interventions: Drug: Varenicline

First Posted Date: 2010-07-26

Last Posted Date: 2019-03-20

Lead Sponsor: Mayo Clinic

Target Recruit Count: 1

Registration Number: NCT01169610

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

Early Phase 1

Active, not recruiting

Conditions: Adult Anaplastic Oligodendroglioma
Adult Diffuse Astrocytoma
Adult Ependymoma
Adult Giant Cell Glioblastoma
Adult Oligodendroglioma
Adult Pilocytic Astrocytoma
Adult Brain Stem Glioma
Adult Anaplastic Astrocytoma
Adult Anaplastic Ependymoma
Adult Mixed Glioma

Interventions: Procedure: biopsy
Procedure: computed tomography
Procedure: therapeutic conventional surgery
Radiation: radiation therapy treatment planning/simulation
Radiation: radiation therapy
Procedure: magnetic resonance imaging
Procedure: positron emission tomography
Drug: fluorine F 18 fluorodopa

First Posted Date: 2010-07-20

Last Posted Date: 2025-02-13

Lead Sponsor: Mayo Clinic

Target Recruit Count: 24

Registration Number: NCT01165632

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy